Daily non-political popular news in brief.

Anticlotting drug found to be safe in sickle cell patients

An intravenous "blood thinner" widely used in patients with acute coronary syndromes and during coronary artery stent placement appears to be safe in patients with sickle cell disease and may have beneficial anti-inflammatory effects, a small study at the University of North Carolina at Chapel Hill School of Medicine has found.

Read more »

Keywords: anticlotting, drug, safe, sickle, cell, patients, patient

« Previous | Next »

Similar news on "Anticlotting drug found to be safe in sickle cell patients":

1. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
   01-31-2008 · EurekAlert!
   Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
   Similar news · Read more »
   
2. A drug's brand name skews patient treatment choices
   05-21-2007 · EurekAlert!
   The brand name of a drug can strongly influence treatment decisions by patients, according to a randomized trial of decision aids by researchers from McMaster University.
   Similar news · Read more »
   
3. Catalyst Pharmaceutical Partners Begins Enrollment for its U.S. Phase II Clinical Trial of CPP-109 in Patients With Cocaine Addiction
   01-25-2008 · Brookhaven National Laboratory
   Catalyst Pharmaceutical Partners, Inc. announced today that it has initiated enrollment of patients for its 180-patient, U.S. Phase II clinical trial evaluating the use of CPP-109 in treating patients with cocaine addiction. CPP-109, an orally administered, small molecule drug which inhibits psychostimulant-induced dopamine release, is Catalyst's lead compound, vigabatrin.
   Similar news · Read more »
   
4. UCI launches effort to develop patient-specific stem cell lines
   05-14-2007 · EurekAlert!
   UC Irvine neurobiologist Hans Keirstead and his research team today launched a project to develop stem cell lines that genetically match human patients. These lines would allow scientists to better study conditions ranging from diabetes to Parkinson's disease, and they would provide the basis for potential patient-specific stem cell treatments.
   Similar news · Read more »
   
5. Cell skeleton may hold key to overcoming drug resistance in cancer
   10-03-2007 · EurekAlert!
   Researchers have uncovered a new way in which a cell protein protects cancer cellsfrom a wide range of chemotherapeutic drugs, identifying a possible target forimproving treatment outcomes for patients.
   Similar news · Read more »
   
6. Widely used hepatitis B drug spurs HIV drug resistance
   02-28-2007 · EurekAlert!
   A Johns Hopkins study has proven false established medical practice that an antiretroviral drug widely used to treat hepatitis B liver infections was safe to use on its own in patients co-infected with HIV. Their findings demonstrate that treatment with entecavir leads to cross-resistance to other antiviral drugs used to treat the AIDS virus.
   Similar news · Read more »
   
7. Annals of Internal Medicine tip sheet for March 20, 2007
   03-19-2007 · EurekAlert!
   The following articles are featured in the upcoming Annals of Internal Medicine: "Flexible Use of Drugs with Close Patient Follow-up Can Successfully Control Rheumatoid Arthritis;" "Osteoporosis Drug Strengthens Bones in Men with Prostate Cancer," and "Experts Show Physicians How to Initiate and Carry Through Timely and Effective Discussions about Hospice with Dying Patients."
   Similar news · Read more »
   
8. Chronic constipation study offers relief to all sufferers
   06-22-2007 · EurekAlert!
   A clinical trial including 50 medical centers and 304 patients has confirmed that polyethylene (PEG) laxative is safe for patients suffering from chronic constipation. The study, published in The American Journal of Gastroenterology, indicates that even elderly patients can use the drug safely for up to six months.
   Similar news · Read more »
   
9. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
   10-10-2007 · EurekAlert!
   Getting the drug dosage correct can be a tricky exercise in trial and error in a disease like multiple sclerosis. Scientists from the Weizmann Institute and the Technion have identified two genes that affect a patient's response to the drug Copaxone, a finding which may help take the some of the guesswork out of treatment.
   Similar news · Read more »
   
10. Leukemia drug proves safe and effective over the long term
    11-07-2007 · EurekAlert!
    The drug imatinib mesylate, more commonly known as Gleevec, proves safe and effective over the long term in patients with an advanced form of chronic myeloid leukemia, according to a study prepublished online in Blood, the official journal of the American Society of Hematology.
    Similar news · Read more »